Business Wire
15 Jun 2026, 17:38 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
A securities class action lawsuit has been filed on behalf of ADMA Biologics (NASDAQ: ADMA) investors for the period between August 9, 2024, and March 25, 2026. — Litigation involving investor losses typically signals potential regulatory issues or material misrepresentations, which can create downward pressure on stock price.
-0.30Which stocks this story touches
The company is the subject of a class action lawsuit following investor losses.
Continue reading
6 related stories
Top 3 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
23m ago
